Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Artesunate-amodiaquine efficacy surveillance for uncomplicated falciparum malaria in Eritrea
ACTRN12625001329459Phase 4Completed
- Sponsor
- Ministry of Health
- Start
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of artesunate and amodiaquine in Malaria, sponsored by Ministry of Health. Primary endpoint: Proportion of treatment failures. Started Sep 2022; status: completed.
02
Drugs
artesunateamodiaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on ACTRN12625001329459.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12625001329459.